01 Development of Centrifuge Free Microfluidic Blood Separation Systems Automated blood processing equipment market analysis shows research into microfluidic systems that separate blood components without conventional centrifugation. These devices use precisely designed channels and fluid dynamics to isolate plasma and blood cells from whole blood. This approach introduces compact automated systems for laboratory automation and decentralized diagnostic facilities, with potential applications in specialized bioprocessing workflows.
02 Adoption of Single Cycle Automation for Multi-Component Blood Recovery Blood centers are adopting automated systems that separate whole blood into red blood cells, plasma, and platelets within one processing cycle. These platforms combine centrifugation, component transfer, sealing, and data capture to standardize blood component preparation. For instance, Terumo Blood and Cell Technologies' Reveos system automates multi-component blood processing at Versiti, which helps reduce manual intervention and improve consistency in platelet preparation.
01 The automated blood processing equipment market forecasts investment in automated blood component separators, apheresis systems, robotic blood collection devices, and integrated processing platforms. In March 2026, Vitestro raised USD 70 million in an oversubscribed Series B financing round. The company develops Aletta, an autonomous robotic blood collection device that uses robotics, artificial intelligence, and imaging to locate veins and collect blood samples.
01 Adoption of Automated Red Blood Cell Washing Systems Drives Market Washed red blood cells are used for patients who require blood components with reduced plasma proteins or other residual substances. Automated cell washing systems help blood banks perform controlled washing, separation, and resuspension steps with consistent processing conditions. Demand for these specialized blood products supports the use of automated red blood cell processing equipment in transfusion facilities.
02 Use of Automated Pathogen Reduction Processing for Platelets and Plasma Boosts Market Growth Blood centers use pathogen reduction technologies to reduce the risk of transfusion-transmitted infections in selected platelet and plasma processing. Automated processing systems help apply controlled treatment protocols while preserving the required properties of blood components. Greater attention to transfusion safety and the availability of treated blood products supports demand for specialized pathogen reduction equipment.
03 Impact Analysis of Key Drivers in Automated Blood Processing Equipment Market Drivers Market Impact Adoption of Automated Blood Component Pooling and Aliquoting Systems Automated pooling and aliquoting systems help blood banks prepare accurately measured units while reducing manual handling and processing variability. Demand for Automated Cryoprecipitate Preparation Cryoprecipitate preparation requires controlled thawing, cold separation, and plasma handling. Use of Automated Pathogen Reduction Processing for Platelets and Plasma Blood centers use pathogen reduction technologies to reduce the risk of transfusion-transmitted infections in selected blood components. Adoption of Automated Red Blood Cell Washing Systems Washed red blood cells are required for selected patients who need products with reduced plasma proteins or other residual substances. Demand for Automated Buffy Coat Removal from Whole Blood Blood centers use automated systems to remove the buffy coat layer, which contains white blood cells and platelets, during whole-blood component preparation.
01 Risk of Platelet Activation During Automated Centrifugation Restraints Market Expansion Automated centrifugation exposes platelets to mechanical stress, pressure changes, and temperature variations during blood component separation. Excessive stress alters platelet function and triggers premature activation. This reduces platelet quality and affects the suitability of processed platelet concentrates for transfusion.
02 Difficulty in Maintaining Closed-System Integrity During Component Processing Limits Market Advancement Automated blood processing equipment relies on sterile tubing, connectors, seals, and transfer pathways to prevent external contamination. Defective connections, seal failures, or pressure-related leaks compromise closed-system integrity. These failures increase microbial contamination risks and lead to component rejection, product loss, and additional quality control requirements.
03 Impact Analysis of Key Restraints in Automated Blood Processing Equipment Market Restraints Market Impact Variability in Blood Component Separation Across Donor Profiles Differences in hematocrit, platelet count, plasma volume, and red blood cell characteristics affect separation behaviour during automated processing. Limited Compatibility With Non-Standard Blood Collection Bags Automated blood processing equipment relies on specific bag dimensions, tubing configurations, connector types, and material properties. Risk of Platelet Activation During Automated Centrifugation Mechanical stress, acceleration profiles, temperature fluctuations, and tubing pressure during automated processing affect platelet processing integrity. Difficulty in Maintaining Closed-System Integrity During Component Processing Connector defects, seal failures, or pressure-related leaks compromise system integrity and increase the risk of microbial contamination or product rejection. Limited Process Flexibility for Low-Volume and Pediatric Blood Collections Standard automated blood processing protocols often rely on predefined collection volumes and separation parameters
01 Automated Blood Processing Equipment for Rare Blood Phenotype Separation Creates Opportunities for Market Players Patients with rare blood groups, such as Rh-null and Bombay phenotypes, often require carefully matched blood components from specialized donor networks. Automated blood processing equipment with precise component separation and controlled collection protocols offers scope for specialized blood banks that manage rare donor units. This niche opens avenues for medical device manufacturers, reference blood laboratories, and rare donor registries that require specialized processing capabilities.
02 Automated Blood Processing Equipment for Extracorporeal Blood Component Collection in Pediatric Care Creates Potential for Market Development Pediatric patients with severe blood disorders sometimes require specialized procedures that involve the collection or separation of specific blood components. Automated apheresis and blood processing systems with low extracorporeal volume and precise fluid control address the need to limit blood volume outside the patient's body. This area creates scope for medical device developers, pediatric hospitals, and specialized apheresis centers that serve children with complex hematological conditions.
October 2026 DEC Group introduced its Automated Blood Bag Processing System (ABBPS), a robotic line that automates tube stripping, sealing, bundling, labelling, and sorting of blood bags.
June 2026 Grifols launched Evanzys IH, a modular, fully automated system for immunohematology sample analysis, with track-enabled workflows for transfusion medicine laboratories.
May 2026 The U.S. Food and Drug Administration cleared Grifols’ Erytra Eflexis automated blood grouping and antibody test system for immunohematology testing.